Amato, Robert J <br/><br/>
Vaccination of prostate cancer patients with modified vaccinia ankara delivering the tumor antigen 5T4 (TroVax): a phase 2 trial.  [electronic resource] 

 -  Journal of immunotherapy (Hagerstown, Md. : 1997)   
 - 577-85 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1524-9557 
<br/><br/><label>Standard No.: </label>10.1097/CJI.0b013e31817deafd  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Cancer Vaccines--immunology<br/>Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology<br/>Humans<br/>Interferon-gamma--biosynthesis<br/>Male<br/>Middle Aged<br/>Prostatic Neoplasms--immunology<br/>Vaccination<br/>Vaccines, DNA<br/>Vaccinia virus--genetics